FDL176

DRUG2 trials

Sponsors

Flatley Discovery Lab LLC

Conditions

Cystic Fibrosis

Phase 1

A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants

CompletedNCT03173573

Flatley Discovery Lab LLCCystic Fibrosis

Start: 2017-06-27End: 2018-05-31Updated: 2018-09-06

A DDI Study of FDL169 and FDL176 in Healthy Subjects

SuspendedNCT03756922

Flatley Discovery Lab LLCCystic Fibrosis

Start: 2018-11-27End: 2020-02-29Target: 78Updated: 2020-02-05